CANNABIDIOL (CBD)

Course overview

CBD IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF THE SEIZURE DISORDERS LENNOX-GASTAUT SYNDROME AND DRAVET SYNDROME. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CBD AS A VALUABLE AGENT IN THE TREATMENT AND MANAGEMENT OF LENNOX-GASTAUT SYNDROME AND DRAVET SYNDROME. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS SUCH AS CURRENT RESEARCH TRIALS ONGOING FOR CBD USE. THIS ACTIVITY IS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT AND MANAGEMENT OF PATIENTS WITH LENNOX-GASTAUT SYNDROME AND DRAVET SYNDROME.